Mental Health Clinics in Kearneysville, WV Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Renovo Center Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 150 E Burr Blvd, Kearneysville, WV 25430 Phone: 681-252-1632 Fax: 300-455-3743 |
Healing Options Providing Empowerment Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 59 Ruland Rd, Kearneysville, WV 25430 Phone: 304-279-5553 Fax: 304-606-3096 |
Continuous Journey Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 179 E Burr Blvd Ste F, Kearneysville, WV 25430 Phone: 304-283-0022 Fax: 304-521-6078 |
Renovo Center Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 150 E Burr Blvd Fl 1, Kearneysville, WV 25430 Phone: 681-252-1632 |
Hidden Peaces Counselor Medicare: Not Enrolled in Medicare Practice Location: 179 E Burr Blvd Ste K, Kearneysville, WV 25430 Phone: 304-238-5330 Fax: 304-512-3388 |
Mountaineer Recovery Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 3094 Charles Town Road, Kearneysville, WV 25430 Phone: 304-901-2070 Fax: 304-885-1054 |
Jefferson Day Report Center, Inc. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 130 E Burr Blvd Fl 1, Kearneysville, WV 25430 Phone: 304-728-3527 Fax: 304-728-3614 |
News Archive
Controlled-release opioids may lead to endocarditis in injection drug users
A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious bacterial heart infection, when compared to those prescribed other opioids.
UTHSC researchers receive $2.4 million to study the role of cholesterol in brain artery health
Alex Dopico, MD, PhD, professor and Van Vleet Chair of Excellence in the Department of Pharmacology, Addiction Science, and Toxicology, and Anna Bukiya, PhD, associate professor in the Department of Pharmacology, Addiction Science, and Toxicology, have been awarded $2.4 million from the National Heart, Lung, and Blood Institute to explore how cholesterol interacts with the mechanisms that modulate blood vessel function in the brain.
HealthCare.com launches new health insurance comparison website
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
OrthoSensor, Stryker partner for intelligent knee surgical trial
Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor Knee Trial, designed for use with Stryker's Triathlon Knee System.
FDA grants orphan drug status to Reata's pancreatic cancer drug
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
› Verified 8 days ago